TY  - CONF

T1  - Plasma G-CSF levels are predictive of lack of response to zoledronic acid treatment in reducing breast cancer recurrence.

JO  - MOLECULAR CANCER RESEARCH

PY  - 2018/08/01

AU  - Ubellacker JM

AU  - Baryawno N

AU  - Severe N

AU  - DeCristo MJ

AU  - Sceneay J

AU  - Haider M-T

AU  - Rhee CS

AU  - Qin Y

AU  - Holen I

AU  - Gregory WM

AU  - Brown JE et al

ED  - 

VL  - 16

IS  - 8

SP  - 68

EP  - 69

Y2  - 2024/12/21

ER  -